NCCN Receives Esteemed Accreditation for CME Activities
NCCN has received Accreditation with Commendation from the ACCME in recognition of relevant, effective, practice-based continuing medical education. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded Accreditation with Commendation for six years as a provider of continuing medical education (CME) for physicians. ACCME accreditation seeks to assure the medical community ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - December 19, 2013 Category: Cancer & Oncology Source Type: news

NCCN Publishes New Patient Resource for Stage 0 Breast Cancer
New NCCN Guidelines for Patients®: Stage 0 Breast Cancer is now available free-of-charge on NCCN.org/patients; NCCN Guidelines for Patients® are educational resources that offer patient-friendly treatment information FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of NCCN Guidelines for Patients®: Stage 0 Breast Cancer-the latest addition to the library of NCCN Guidelines for Patients® available f... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - December 1, 2013 Category: Cancer & Oncology Source Type: news

NCCN Qualifies Northside Hospital Cancer Institute for Affiliate Research Project
As the tenth approved member of the NCCN Affiliate Research Project (ARP), Northside Hospital Cancer Institute and its investigators and patients will gain access to new and innovative cancer drugs. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Affiliate Research Project (ARP), developed by the NCCN Oncology Research Program (ORP), has qualified Northside Hospital Cancer Institute for the project. Northside Hospital Cancer Institute is a community-based associate ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 26, 2013 Category: Cancer & Oncology Source Type: news

“Harvard Study Shows that Nuts May Reduce Risk of Death”,
New Harvard research provides the strongest evidence to date that eating nuts can reduce a person's risk of dying from cancer, heart disease, and a number of other causes. Research for this study was conducted at Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center-one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 20, 2013 Category: Cancer & Oncology Source Type: news

“Oral Drug May Improve Survival in Men with Metastatic Prostate Cancer”, Duke Cancer Institute
An investigational prostate cancer treatment slows the disease's progression and may increase survival, especially among men whose cancer has spread to the bones, according an analysis led by the Duke Cancer Institute-one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 19, 2013 Category: Cancer & Oncology Source Type: news

“How Doctors Die: Showing Others the Way”,
This article explores how physicians, with their advanced knowledge of medical treatment, outcomes and potential side effects, approach end-of-life decision-making. Following a number of physicians who have been diagnosed with cancer, this article mentions several NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 19, 2013 Category: Cancer & Oncology Source Type: news

“Anal Cancer Study Offers Hope of Treatment”,
This article discusses ongoing research regarding the use of HPV vaccines in prevention of anal cancer, as well as subsequent screening and other preventative routines and treatments in patients at higher risk of developing this rare form of cancer. This article features commentary from a physician at UCSF Helen Diller Family Comprehensive Cancer Center-one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 19, 2013 Category: Cancer & Oncology Source Type: news

“Treatment, Survival for Colon Cancer Differs by Race”, Reuters.com
This article features commentary from a physician from UC San Diego Moores Cancer Center - one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 19, 2013 Category: Cancer & Oncology Source Type: news

“Broccoli Not Burgers: Cancer Patients Favor Healthier Foods”, Reuters.com
This article features commentary from experts at Dana-Farber/Brigh... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 19, 2013 Category: Cancer & Oncology Source Type: news

“Adult Survivors of Childhood Cancer at Risk of Becoming Frail at an Early Age”, St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
Young adults who survived childhood cancer are more likely than their peers to be frail, according to a St. Jude Children's Research Hospital study, which reported the condition is more common among female survivors than women decades older. The research appears in the current edition of the Journal of Clinical Oncology. St. Jude Children's Research Hospital/The University of Tennessee Health Science Center is one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 18, 2013 Category: Cancer & Oncology Source Type: news

“Breast MRI Use Up Despite Lack of Indications”, MedPage Today
This article features commentary from physicians at Duke Cancer Institute and The University of Texas MD Anderson Cancer Center-two of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 18, 2013 Category: Cancer & Oncology Source Type: news

Researchers Receive Grants from NCCN Oncology Research Program Funded through Onyx Pharmaceuticals
The NCCN Oncology Research Program (ORP) has awarded four research grants to investigators to scientifically evaluate and define clinical effectiveness of carfilzomib and oprozomib in non-Hodgkin lymphomas; The four grants are the result of funding from Onyx Pharmaceuticals. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) recently awarded four research grants to investigators following NCCN ORP Scientific Review Committee analysis of ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 17, 2013 Category: Cancer & Oncology Source Type: news

“Secret to Surviving Cancer? It might be Marriage”,
This article features commentary from a radiation oncologist at Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 15, 2013 Category: Cancer & Oncology Source Type: news

“Most Men with Breast Cancer Undergo Mastectomy, Study Finds”, U.S. News and World Report
This study was authored at the University of Colorado Cancer Center-one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 15, 2013 Category: Cancer & Oncology Source Type: news

“Long-Term Colorectal Cancer Incidence and Mortality after Lower Endoscopy”,
Colonoscopy and sigmoidoscopy have been shown to provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against proximal colon cancer, remain undefined. A study of long-term colorectal cancer incidence and mortality after lower endoscopy reported in The New England Journal of Medicine by Reiko Nishihara, PhD, of Dana-Farber Cancer Institute and Harvard Medical School, and colleagues found that both colonoscopy and sigmoidoscopy for any indication... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 15, 2013 Category: Cancer & Oncology Source Type: news